PTC Therapeutics Inc. (PTCT) Hits New 52-week Low During January 11 Session

Equities Staff |

PTC Therapeutics Inc. (PTCT) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $26.50, PTC Therapeutics Inc. dropped to $22.65 for a new 52-week low. By the closing bell, the company's stock was at $22.68 a share for a loss of 13.83%.

Falling to a new 52-week low is never fun for company's shareholder, but, depending on who you ask, it can be either a buy or a sell signal. Someone bearish on the stock might see it reaching its lowest price in a year as a sign of growing downward momentum and make sure they sell their shares. Bulls, though, are more likely to see a new 52-week low as the stock hitting its low point and anticipate a bounce in the share price.

However one plays it, it's often a critical moment for any stock and should be noted by investors.

PTC Therapeutics Inc. saw 718,584 shares of its stock trade hands, that's out of 34.27 million shares outstand. The stock has an average daily volume of 976,899 shares. After hitting a new 52-week low, PTC Therapeutics Inc. enters the new trading day with a market cap of 777.28 million, a 50-day SMA of $29.52 and a 200-day SMA of $43.45

For a complete fundamental analysis analysis of PTC Therapeutics Inc., check out Equities.com’s Stock Valuation Analysis report for PTCT. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

PTC Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes.

PTC Therapeutics Inc. has 193 employees, is led by CEO Stuart W. Peltz, and makes its home in South Plainfield, NJ.

PTC Therapeutics Inc. is also a component of the Russell 2000 Index, which is generally viewed as the most reliable indicator of the health of the broader small-cap market. Using a rules-based methodology, it creates a simple, unbiased view of how America's stable of smaller publicly traded companies are performing in the stock markets.

The index consists of the 2,000 smallest companies of the 3,000 largest publicly-traded companies in the country as judged by market cap. It's constructed by Russell Investments, which also builds and maintains the Russell 3000 (an index consisting of all 3,000 biggest companies by market cap) and the large-cap Russell 1000 (which has the 1,000 largest companies from the Russell 3000).

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Altair Resources Inc.

Altair Resources Inc, formerly Altair Gold Inc acquires, explores and develops mineral properties in Canada. The Company is in the process of exploring its mineral properties.

Private Markets

Snapchat

Snapchat is the fastest way to share a moment with friends. The mobile app, allows users to not only share photos with friends but also control how long they can…

Airbnb

Airbnb is a community marketplace for people to list, discover, and book unique accommodations around the world — online or from a mobile phone. Whether an apartment for a night,…